Nhu Thi Hoa

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study

Rob W. van der Pluijm, Mallika Imwong, Nguyễn Hoàng Châu et al. · The Lancet Infectious Diseases · 2019 · 413 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

Rob W. van der Pluijm, Rupam Tripura, Richard M. Hoglund et al. · The Lancet · 2020 · 280 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Estimation of the <i>In Vivo</i> MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria

Tran Tinh Hien, Nicholas J. White, Thuy-Nhien Nguyen et al. · Antimicrobial Agents and Chemotherapy · 2016 · 33 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

A Randomized Comparison of Chloroquine Versus Dihydroartemisinin–Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam

Phung Duc Thuan, Nguyen Thuy Nha Ca, Pham Van Toi et al. · American Journal of Tropical Medicine and Hygiene · 2016 · 21 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +13

Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial

Iván Darío Vélez, Tran Tinh Hien, Justin A. Green et al. · The Lancet Child & Adolescent Health · 2021 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +14